Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Esophageal Diseases
>>
Tyrosine Kinase Inhibitors
>>
Phase 2
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
sunitinib
/ Generic mfg.
sorafenib
/ Generic mfg.
everolimus
/ Generic mfg.
matuzumab
(EMD 72000) / Takeda, EMD Serono
Cyramza
(ramucirumab) / Eli Lilly
Gilotrif
(afatinib) / Boehringer Ingelheim
MM 111
/ Elevation Oncology
Vizimpro
(dacomitinib) / Pfizer
brivanib alaninate
(BMS-582664) / ZAI Lab
trebananib
(AMG 386) / Amgen
varlitinib
(ASLAN001) / ASLAN Pharma
